| TSHA |
Taysha Gene Therapies, Inc. |
12 Jan 2026 |
2 |
$0 |
4 |
Chief Executive Officer, Director |
14 Jan 2026, 16:45 |
| VTR |
Ventas, Inc. |
13 May 2025 |
1 |
+$184,967 |
4 |
Director |
15 May 2025, 16:54 |
| TSHA |
Taysha Gene Therapies, Inc. |
02 Jan 2025 |
2 |
$0 |
4 |
Chief Executive Officer, Director |
03 Jan 2025, 17:38 |
| VTR |
Ventas, Inc. |
14 May 2024 |
1 |
+$174,958 |
4 |
Director |
16 May 2024, 17:01 |
| TSHA |
Taysha Gene Therapies, Inc. |
02 Jan 2024 |
2 |
$0 |
4 |
Chief Executive Officer, Director |
04 Jan 2024, 16:41 |
| TSHA |
Taysha Gene Therapies, Inc. |
14 Dec 2023 |
1 |
$0 |
4 |
Chief Executive Officer, Director |
18 Dec 2023, 16:46 |
| TSHA |
Taysha Gene Therapies, Inc. |
16 Aug 2023 |
1 |
+$400,000 |
4 |
Chief Executive Officer, Director |
16 Aug 2023, 21:52 |
| VTR |
Ventas, Inc. |
16 May 2023 |
1 |
+$174,991 |
4 |
Director |
18 May 2023, 16:48 |
| TSHA |
Taysha Gene Therapies, Inc. |
30 Dec 2022 |
1 |
$0 |
4 |
Chief Executive Officer, Director |
04 Jan 2023, 15:51 |
| TSHA |
Taysha Gene Therapies, Inc. |
17 Jun 2022 |
1 |
$0 |
4 |
Director |
22 Jun 2022, 16:38 |
| VTR |
Ventas, Inc. |
27 Apr 2022 |
1 |
+$174,956 |
4 |
Director |
29 Apr 2022, 16:50 |
| /report/000120919121057634-nolan-sean-p-2021-09-24 |
Social Capital Suvretta Holdings Corp. II |
24 Sep 2021 |
0 |
$0 |
3 |
Director |
24 Sep 2021, 16:51 |
| TSHA |
Taysha Gene Therapies, Inc. |
17 Jun 2021 |
1 |
$0 |
4 |
Director |
21 Jun 2021, 17:02 |
| VTR |
Ventas, Inc. |
25 May 2021 |
1 |
$0 |
4 |
Director |
27 May 2021, 17:28 |
| TSHA |
Taysha Gene Therapies, Inc. |
20 May 2021 |
1 |
+$26,150 |
4 |
Director |
24 May 2021, 08:39 |